Ownership history in Redmile Group, LLC · 8 quarters on record
This page tracks every 13F SEC filing in which Redmile Group, LLC reported a position in SILENCE THERAPEUTICS PLC (SLN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 2,164,777 | — | 0% | 0.97% | $13.2M | $6.08 |
| 2025 Q3 | UNCHANGED | 2,164,777 | — | 0% | 1.09% | $11.2M | $5.19 |
| 2025 Q2 | REDUCED | 2,164,777 | -50,170 | -2.3% | 1.34% | $12.6M | $5.80 |
| 2025 Q1 | REDUCED | 2,214,947 | -184,370 | -7.7% | 0.59% | $6.2M | $2.82 |
| 2024 Q4 | ADDED | 2,399,317 | +500,000 | +26.3% | 1.15% | $16.5M | $6.88 |
| 2024 Q3 | REDUCED | 1,899,317 | -114,979 | -5.7% | 2.03% | $34.5M | $18.18 |
| 2024 Q2 | REDUCED | 2,014,296 | -13,373 | -0.7% | 2.31% | $38.3M | $19.00 |
| 2024 Q1 | INITIATED | 2,027,669 | — | — | 1.61% | $43.8M | — |
As of 2025 Q4 — sorted by position size